Proliferative signaling pathways

Proliferative signaling pathways encompass a diverse and complex network of biochemical cascades that regulate fundamental cellular processes including growth, division, and survival. Key examples include the Mitogen-Activated Protein Kinase (MAPK/ERK) pathway and the Phosphoinositide 3-kinase (PI3K)/Akt/mTOR pathway, which translate extracellular signals from growth factors into nuclear transcriptional changes (Hanahan & Weinberg, 2011, Cell). In a physiological context, these pathways are strictly regulated to maintain tissue homeostasis; however, their constitutive activation is a primary driver of oncogenesis and other hyperproliferative disorders (Sever & Brugge, 2015, Cold Spring Harb Perspect Med). Therapeutic strategies generally involve the use of small molecule inhibitors or monoclonal antibodies designed to target specific mutated or overexpressed proteins within these cascades. While highly effective in the short term, the clinical utility of these drugs is often limited by the redundancy of signaling networks and the rapid development of compensatory resistance mechanisms (NIH, National Cancer Institute).

Other names

Cell proliferation pathwaysMitogenic signaling cascadesGrowth factor signaling pathwaysSustained proliferative signaling

Drugs targeting these pathways typically act by inhibiting specific nodes such as receptor tyrosine kinases (RTKs), intracellular kinases (e.g., RAF, MEK, PI3K), or downstream effectors to arrest the cell cycle and induce apoptosis (NIH, National Cancer Institute).